2011
DOI: 10.4103/0378-6323.77496
|View full text |Cite
|
Sign up to set email alerts
|

Primary cutaneous CD30+ lymphoproliferative disorder in an atopic dermatitis patient on cyclosporine therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 5 publications
1
11
0
Order By: Relevance
“…Although not observed by us, several cases of pcALCL occurring in patients with atopic dermatitis have been reported, often in the context of cyclosporine therapy given for the atopic dermatitis. [13,14] In agreement with our previous study, [2] IgE-t GM values of supplemental patients progressively increased from LyP-B to LyP-A to LyP-C, and with increasing categories of CD30 + dermal cells below 50% in the skin specimen obtained at the time of blood sampling. This observation suggests that the atypical CD30+ cells might be influencing IgE production.…”
Section: Discussionsupporting
confidence: 91%
“…Although not observed by us, several cases of pcALCL occurring in patients with atopic dermatitis have been reported, often in the context of cyclosporine therapy given for the atopic dermatitis. [13,14] In agreement with our previous study, [2] IgE-t GM values of supplemental patients progressively increased from LyP-B to LyP-A to LyP-C, and with increasing categories of CD30 + dermal cells below 50% in the skin specimen obtained at the time of blood sampling. This observation suggests that the atypical CD30+ cells might be influencing IgE production.…”
Section: Discussionsupporting
confidence: 91%
“…renal dysfunction) in older adults. 76 Narrowband ultraviolet B at a dose of approximately 0.35-0.65 J/cm 2 per irradiation appears extremely effective for elderly AD. 77,78 Therapeutic patient education 79 and a psychodermatological approach 80 are also useful for avoiding trigger factors and modifying problematic behaviors, such as habitual scratching.…”
Section: Managementmentioning
confidence: 97%
“…As other adjunctive treatments, oral cyclosporine is very effective for the treatment of severe cases of elderly AD, but clinicians must pay attention to the increased risk of malignancy and organ toxicity (e.g. renal dysfunction) in older adults . Narrowband ultraviolet B at a dose of approximately 0.35–0.65 J/cm 2 per irradiation appears extremely effective for elderly AD .…”
Section: Diagnosis and Management Of Elderly Admentioning
confidence: 99%
“…She had been diagnosed with AD in early childhood and had been suffering from it ever since. Cyclosporine arguably increases the risk of developing lymphoma [1,[3][4][5][6] and ALCL occurrence has been reported in a psoriatic patient treated with cyclosporine [8]. From age 32, she had repeatedly developed multiple small nodules on her scalp, face, trunk, and extremities.…”
Section: Atopic Dermatitis With Cd30-positive Anaplastic Large Cell Lmentioning
confidence: 99%
“…Platelet activation may be a link in the pathophysiology of diseases prone to thrombosis and inflammation [3]. Elevation of MPV values has been shown to be an independent risk factor in acute myocardial infarction, hyperlipidemia and diabetes mellitus [5,6]. Elevation of MPV values has been shown to be an independent risk factor in acute myocardial infarction, hyperlipidemia and diabetes mellitus [5,6].…”
Section: Mean Platelet Volume Variation After Biologic Therapy In Psomentioning
confidence: 99%